Notoginsenoside R1 attenuates brain injury in rats with traumatic brain injury: Possible mediation of apoptosis via ERK1/2 signaling pathway
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0295903 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Xiaoxian Pei und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatric, The Fourth People's Hospital of Zhangjiagang City, Suzhou, China. Hauptthemen laut MEDLINE: Brain Injuries, Traumatic, Neuroprotective Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Suzhou Gusu Health Talents Scientific Research Project, Zhangjiagang Fourth People's Hospital Research Project.
Abstract (Originalsprache)
Traumatic brain injury (TBI) occurs worldwide and is associated with high mortality and disability rate. Apoptosis induced by TBI is one of the important causes of secondary injury after TBI. Notoginsenoside R1 (NGR1) is the main phytoestrogen extracted from Panax notoginseng. Many studies have shown that NGR1 has potent neuroprotective, anti-inflammatory, and anti-apoptotic properties and is effective in ischemia-reperfusion injury. Therefore, we investigated the potential neuroprotective effects of NGR1 after TBI and explored its molecular mechanism of action. A rat model of TBI was established using the controlled cortical impact (CCI) method. The expression levels of Bcl-2, Bax, caspase 3, and ERK1/2-related molecules in the downstream pathway were also detected by western blotting. The expression levels of pro-inflammatory cytokines were detected by real-time quantitative PCR. Nissl staining was used to clarify the morphological changes around the injury foci in rats after TBI. Fluoro-Jade B (FJB) and terminal deoxynucleotidyl transferase (TdT) dUTP Nick-End Labeling (TUNEL) fluorescence staining were used to detect the apoptosis of neural cells in each group of rats. The results showed that NGR1 administration reduced neurological deficits after TBI, as well as brain edema and brain tissue apoptosis. It also significantly inhibited the expression of pro-inflammatory cytokines. Furthermore, NGR1 decreased the expression levels of extracellular signal-regulated kinase (ERK) and p-RSK1, which are phosphorylated after trauma. This study suggests that NGR1 can improve neuronal apoptosis in brain injury by inhibiting the ERK signaling pathway. NGR1 is a potential novel neuroprotective agent for the treatment of secondary brain injury after TBI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Psychiatric, The Fourth People's Hospital of Zhangjiagang City, Suzhou, China.
- Medical College of Soochow University, Suzhou, China.
- Translational Medicine Center, The First People's Hospital of Zhangjiagang City, Suzhou, China.
- Department of Psychiatric, Suzhou Guangji Hospital, The Affiliated Guangji Hospital of Soochow University, Suzhou, China.
ORCID-Profile: Xiaoxian Pei
Förderung
- Suzhou Gusu Health Talents Scientific Research Project
- Zhangjiagang Fourth People's Hospital Research Project
Zitieren
APA
Pei, X., Zhang, L., Liu, D., Wu, Y., Li, X., Cao, Y., & Du, X. (2023). Notoginsenoside R1 attenuates brain injury in rats with traumatic brain injury: Possible mediation of apoptosis via ERK1/2 signaling pathway. PLOS ONE. https://doi.org/10.1371/journal.pone.0295903
Vancouver
Pei X, Zhang L, Liu D, Wu Y, Li X, Cao Y, et al. Notoginsenoside R1 attenuates brain injury in rats with traumatic brain injury: Possible mediation of apoptosis via ERK1/2 signaling pathway. PLOS ONE. 2023. doi:10.1371/journal.pone.0295903
BibTeX
@article{Pei2023,
author = {Pei, Xiaoxian and Zhang, Ling and Liu, Dan and Wu, Yajuan and Li, Xiaowei and Cao, Ying and Du, Xiangdong},
title = {Notoginsenoside R1 attenuates brain injury in rats with traumatic brain injury: Possible mediation of apoptosis via ERK1/2 signaling pathway},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0295903}
}
EUVIMED